Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-045916
Filing Date
2021-11-23
Accepted
2021-11-23 20:58:41
Documents
2
Period of Report
2021-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7186
2 EX-24 DOCUMENT attachment1.htm EX-24 4715
  Complete submission text file 0000899243-21-045916.txt   13259
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IKENA ONCOLOGY, INC. 645 SUMMER STREET SUITE 101 BOSTON MA 02210
Business Address
Zhang Xiaoyan Michelle (Reporting) CIK: 0001895321 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40287 | Film No.: 211440851